Entrapment and release difference resulting from hydrogen bonding interactions in niosome

Abd-Elbary, 2008, Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium, Int. J. Pharm., 357, 189, 10.1016/j.ijpharm.2008.01.056 Aggarwal, 2004, Development of a topical niosomal preparation of acetazolamide: preparation and evaluation, J. Pharm. Pharmacol., 56, 1509, 10.1211/0022357044896 Alsarra, 2009, Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery, J. Microencapsul., 26, 272, 10.1080/02652040802305618 Arunothayanun, 2000, The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether, Int. J. Pharm., 201, 7, 10.1016/S0378-5173(00)00362-8 Arunothayanun, 1999, Preparation and in vitro in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical tubular niosomes, J. Pharm. Sci., 88, 34, 10.1021/js980286u Assadullahi, 1991, Liposome formation from systhetic polyhydroxyl lipids, Biochim. Biophys. Acta, 1083, 271, 10.1016/0005-2760(91)90082-S Azmin, 1985, The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice, J. Pharm. Pharmacol., 37, 237, 10.1111/j.2042-7158.1985.tb05051.x Bandak, 1999, Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes, Pharm. Res., 16, 841, 10.1023/A:1018869818282 Bandyopadhyay, 2007, Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release, Colloid Surf. B: Biointerfaces, 58, 68, 10.1016/j.colsurfb.2007.01.014 Barakat, 2009, Development of naftifine hydrochloride alcohol-free niosome gel, Drug Dev. Ind. Pharm., 35, 631, 10.1080/03639040802498864 Bayindir, 2010, Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery, J. Pharm. Sci., 99, 2049, 10.1002/jps.21944 Degier, 1968, Lipid composition and permeability of liposomes, Biochim. Biophys. Acta, 150, 666, 10.1016/0005-2736(68)90056-4 EL-Samaligy, 2006, Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation, Int. J. Pharm., 308, 140, 10.1016/j.ijpharm.2005.11.006 Fenton, 1997, Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes. [(R)- and (S)-3-aminohexahydroazepine]dichloro- platinum(II). Crystal structure of the S enantiomer, J. Med. Chem., 40, 1090, 10.1021/jm9607966 Fukuyama, 1973, Crystal-structure of piperdinium para-hydroxybenzoate, Acta Crystallogr. Sect. B, 29, 2713, 10.1107/S0567740873007429 Gude, 2002, Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model, Cancer Biother. Radiopharm., 17, 183, 10.1089/108497802753773801 Hao, 2002, Studies on a high encapsulation of colchicine by a niosome system, Int. J. Pharm., 244, 73, 10.1016/S0378-5173(02)00301-0 Hong, 2009, Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferring, J. Control. Release, 133, 96, 10.1016/j.jconrel.2008.09.005 Hu, 1999, Proniosomes: a novel drug carrier preparation, Int. J. Pharm., 185, 23, 10.1016/S0378-5173(99)00122-2 Junyaprasert, 2008, Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes, AAPS PharmSciTech, 9, 851, 10.1208/s12249-008-9121-1 Loftsson, 1996, The effect of water-soluble polymers on aqueous solubility of drugs, Int. J. Pharm., 127, 293, 10.1016/0378-5173(95)04207-5 Mainardes, 2004, Drug delivery systems: past, present, and future, Curr. Drug Targets, 5, 449, 10.2174/1389450043345407 Manconi, 2006, Niosomes as carriers for tretinoin III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin, Int. J. Pharm., 311, 11, 10.1016/j.ijpharm.2005.11.045 Manosroi, 2008, Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid, Int. J. Pharm., 352, 248, 10.1016/j.ijpharm.2007.10.013 Manosroi, 2005, The entrapment of kojic oleate in bilayer vesicles, Int. J. Pharm., 298, 13, 10.1016/j.ijpharm.2005.02.041 Mokhtar, 2008, Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes, Int. J. Pharm., 361, 104, 10.1016/j.ijpharm.2008.05.031 Nasr, 2008, Vesicular aceclofenac systems: a comparative study between liposomes and niosomes, J. Microencapsul., 25, 499, 10.1080/02652040802055411 Paolino, 2008, Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer, Int. J. Pharm., 353, 233, 10.1016/j.ijpharm.2007.11.037 Paolino, 2007, In vitro and in vivo evaluation of bola-surfactant containing niosomes for transdermal delivery, Biomed. Microdev., 9, 421, 10.1007/s10544-007-9046-6 Pardakhty, 2007, In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin, Int. J. Pharm., 328, 130, 10.1016/j.ijpharm.2006.08.002 Parshad, 2004, Aqueous solubility study of salts of benzylamine derivatives and p-substituted benzoic acid derivatives using X-ray crystallographic analysis, Int. J. Pharm., 269, 157, 10.1016/j.ijpharm.2003.09.009 Quah, 2008, 3-Aminobenzoic acid-4-nitrobenzoic acid (1/1), Acta Crystallogr. Sect. E, 64, o2230, 10.1107/S1600536808034934 Shi, 2006, Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity, J. Pharm. Sci., 95, 1873, 10.1002/jps.20491 Speight, 2005 Stalin, 2005, Spectral characteristics of ortho, meta and para dihydroxy benzenes in different solvents, pH and beta-cyclodextrin, Spectrochim. Acta Part A: Mol. Biomol. Spectrosc., 61, 2495, 10.1016/j.saa.2004.08.024 Uchegbu, 1998, Non-ionic surfactant based vesicles (niosomes) in drug delivery, Int. J. Pharm., 172, 33, 10.1016/S0378-5173(98)00169-0 Vora, 1998, Proniosome based transdermal delivery of levonorgestrel for effective contraception, J. Control. Release, 54, 149, 10.1016/S0168-3659(97)00100-4 Zhao, 1998, The inhibition effect of p-hydroxybenzoic acid on tyrosinase, Acta Sci. Nat. Univ. Jilin, 4, 89